Shares of Texas Instruments Incorporated (NASDAQ:TXN – Get Free Report) have received a consensus rating of “Hold” from the twenty-one ratings firms that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and eight have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $204.67.
Several research firms have recently weighed in on TXN. KeyCorp increased their price target on Texas Instruments from $200.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. The Goldman Sachs Group increased their price target on Texas Instruments from $157.00 to $176.00 and gave the company a “sell” rating in a report on Wednesday, July 24th. Citigroup raised Texas Instruments from a “neutral” rating to a “buy” rating and increased their price target for the company from $200.00 to $235.00 in a report on Wednesday, August 21st. Jefferies Financial Group increased their price target on Texas Instruments from $175.00 to $185.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. Finally, Stifel Nicolaus increased their price target on Texas Instruments from $172.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, July 18th.
Get Our Latest Stock Report on TXN
Texas Instruments Stock Performance
Texas Instruments (NASDAQ:TXN – Get Free Report) last released its quarterly earnings data on Tuesday, July 23rd. The semiconductor company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.06. The business had revenue of $3.82 billion for the quarter, compared to analysts’ expectations of $3.82 billion. Texas Instruments had a return on equity of 31.10% and a net margin of 33.01%. The firm’s quarterly revenue was down 15.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.87 EPS. As a group, research analysts forecast that Texas Instruments will post 5.11 earnings per share for the current fiscal year.
Texas Instruments Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 12th. Investors of record on Thursday, October 31st will be issued a $1.36 dividend. This is an increase from Texas Instruments’s previous quarterly dividend of $1.30. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $5.44 dividend on an annualized basis and a dividend yield of 2.70%. Texas Instruments’s dividend payout ratio (DPR) is presently 84.87%.
Insider Activity at Texas Instruments
In related news, VP Shanon J. Leonard sold 2,816 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $208.91, for a total value of $588,290.56. Following the completion of the transaction, the vice president now owns 24,112 shares of the company’s stock, valued at approximately $5,037,237.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Texas Instruments news, CEO Haviv Ilan sold 1,200 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $209.44, for a total transaction of $251,328.00. Following the completion of the transaction, the chief executive officer now owns 158,676 shares in the company, valued at $33,233,101.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Shanon J. Leonard sold 2,816 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $208.91, for a total value of $588,290.56. Following the transaction, the vice president now owns 24,112 shares of the company’s stock, valued at approximately $5,037,237.92. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,558 shares of company stock valued at $3,255,323. Insiders own 0.68% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the business. Richardson Financial Services Inc. purchased a new position in shares of Texas Instruments during the fourth quarter valued at approximately $26,000. Scarborough Advisors LLC purchased a new stake in shares of Texas Instruments in the fourth quarter valued at approximately $26,000. Westend Capital Management LLC purchased a new stake in shares of Texas Instruments in the first quarter valued at approximately $31,000. Norwood Financial Corp purchased a new stake in shares of Texas Instruments in the first quarter valued at approximately $32,000. Finally, Fortis Group Advisors LLC boosted its holdings in shares of Texas Instruments by 100.0% in the fourth quarter. Fortis Group Advisors LLC now owns 196 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 98 shares during the period. Hedge funds and other institutional investors own 84.99% of the company’s stock.
Texas Instruments Company Profile
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. The company operates through Analog and Embedded Processing segments. The Analog segment offers power products to manage power requirements across various voltage levels, including battery-management solutions, DC/DC switching regulators, AC/DC and isolated controllers and converters, power switches, linear regulators, voltage references, and lighting products.
Recommended Stories
- Five stocks we like better than Texas Instruments
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Energy Stocks Fueling the AI Datacenter Boom
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Texas Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Texas Instruments and related companies with MarketBeat.com's FREE daily email newsletter.